KINNATE BIOPHARMA
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of targeted therapeutics by developing products for underserved populations. The company utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine. Its programs include candidates in preclinical development for cancers that are driven by specific oncogenic alterations in either the BRAF kinase gene or in the FGFR2 and FGFR3 kinase genes.
KINNATE BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.kinnate.com
Total Employee:
51+
Status:
Active
Total Funding:
194.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins
Current Advisors List
Board_member
2020-04-01
Board_member
Board_member
Board_member
Current Employees Featured
Nima Farzan Chief Executive Officer @ Kinnate Biopharma
Chief Executive Officer
2020-05-01
Eric A Murphy Co-Founder and Chief Scientific Officer @ Kinnate Biopharma
Co-Founder and Chief Scientific Officer
Richard Williams Chief Medical Officer (CMO) @ Kinnate Biopharma
Chief Medical Officer (CMO)
2020-06-01
Founder
Stock Details
Investors List
Vida Ventures
Vida Ventures investment in Series C - Kinnate Biopharma
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Kinnate Biopharma
RA Capital Management
RA Capital Management investment in Series C - Kinnate Biopharma
Foresite Capital
Foresite Capital investment in Series C - Kinnate Biopharma
Leerink Partners
Leerink Partners investment in Series C - Kinnate Biopharma
Logos Capital
Logos Capital investment in Series C - Kinnate Biopharma
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Kinnate Biopharma
Nextech Invest
Nextech Invest investment in Series C - Kinnate Biopharma
Boxer Capital
Boxer Capital investment in Series C - Kinnate Biopharma
OrbiMed
OrbiMed investment in Series C - Kinnate Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-09 | Kinnate Adds WuXi NextCODE’s Richard Williams as Chief Medical Officer |
Official Site Inspections
http://www.kinnate.com Semrush global rank: 245.56 K Semrush visits lastest month: 284.97 K
- Host name: 23.98.198.104.bc.googleusercontent.com
- IP address: 104.198.98.23
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Kinnate Biopharma"
Kinnate Biopharma - Crunchbase Company Profile
Kinnate Biopharma may be growing as evidenced by the company being the target of a tender offer and subsequent acquisition by XOMA Corporation. The acquisition agreement included a cash per share offer ranging from $2.3352 to …See details»
Corporate Profile | Kinnate Biopharma
Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is developing …See details»
Kinnate Biopharma Inc. - AnnualReports.com
Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is developing …See details»
Kinnate Biopharma Company Profile - Office Locations ... - Craft
Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. It utilizes …See details»
Kinnate Biopharma Inc. Company Profile | San Francisco, CA ...
Added by Kinnate Biopharma Inc. This information is updated and provided by Kinnate Biopharma Inc. The content available on the D&B Business Directory is provided "as-is" and "as …See details»
Kinnate Biopharma - Overview, News & Similar companies
Feb 18, 2024 Kinnate Biopharma Inc. is a precision oncology company driven by our mission to deliver better outcomes for patients with limited treatment options . Our focused portfolio of …See details»
Kinnate Biopharma
Dec 5, 2024 Kinnate Biopharma was founded in 2019 as a spin-off from the Johns Hopkins University School of Medicine. We strive to build a diverse and collaborative team, and are …See details»
XOMA acquires Kinnate Biopharma - 2024-02-16 - Crunchbase
Feb 16, 2024 Acquiring Organization: XOMA XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation. ... Kinnate …See details»
Investor FAQs - Kinnate Biopharma
Dec 3, 2020 Who is Kinnate Biopharma's transfer agent and how do I contact them? Our transfer agent is: American Stock Transfer & Trust Company Address: 6201 15th Avenue, …See details»
Investor Presentation - investors.kinnate.com
Productive Kinnate Drug Discovery Engine powered by structure-based drug discovery, translational research and patient-driven precision medicine • 3 Years from inception to initial …See details»
Kinnate Biopharma - Funding, Financials, Valuation & Investors
Kinnate Biopharma is registered under the ticker NASDAQ:KNTE . Their stock opened with $20.00 in its Dec 2, 2020 IPO. Stock Symbol NASDAQ:KNTE ; Valuation at IPO $830.5M; …See details»
Kinnate’s Competitors, Revenue, Number of Employees, Funding
Kinnate’s Profile, Revenue and Employees. Kinnate is a California-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of …See details»
Kinnate Biopharma Inc. - Wikidata
Oncology therapeutics companySee details»
Kinnate Biopharma, Inc. (Kinnate Biopharma, Inc.) - 药物管线_专 …
最近，该实验室从 Kinnate Biopharma 购得泛 RAF 抑制剂 exarafenib，旨在扩展 RAS/RAF 驱动性实体瘤的靶向治疗方案。 这些新增的临床开发产品组合分别通过 encorafenib、binimetinib …See details»
Kinnate Biopharma Inc. Adds Global Business and Oncology …
Jan 26, 2023 SAN FRANCISCO and SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology …See details»
Nima Farzan of Kinnate Biopharma: Five Things You Need To Be A …
Sep 5, 2022 When your organization started, what was its vision, what was its purpose? Kinnate is a clinical-stage precision oncology company. Our purpose is to provide hope to those …See details»
Committee Composition | Kinnate Biopharma
Minimum 15 minutes delayed. Source: LSEG. Investor Tools. Committee CompositionSee details»
Kinnate Biopharma - Contacts, Employees, Board Members
Organization. Kinnate Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Kinnate Biopharma has 1 …See details»
Science & Pipeline - Kinnate Biopharma Inc.
Exarafenib (KIN-2787) is an orally administered, potent and selective investigational small molecule pan-RAF inhibitor. KN-8701 is an ongoing, global Phase 1 clinical trial …See details»
Raider Nation Origin Stories: Meet Josh Caminite, founder of …
1 day ago He created Vegas Raider Dad in 2022, a nonprofit organization that gifts opportunities and experiences for children and their parents to attend sporting events. So far, the …See details»